Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

DON ALFONSO

NPI
1073508917
CMS profile
320483
Location
PALM COAST, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2022 · Entire year

$435.13

30 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2022 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $435.13 30

By paying entity

PY2022 · entire year · sorted by reported total

Page 1 of 1; records 1–30 of 30 matching records. This page contains 30 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

DON ALFONSO

NPI 1073508917 · CMS profile ID 320483

PALM COAST, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–30 of 30 matching records. This page contains 30 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1073508917?year=2022&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
DON ALFONSO, NPI 1073508917, CMS profile ID 320483. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–30 of 30 matching records. This page contains 30 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1073508917?year=2022&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
APA 7
IndustryPayments. (2026). DON ALFONSO, NPI 1073508917, CMS profile ID 320483. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–30 of 30 matching records. This page contains 30 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1073508917?year=2022&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
Bluebook
DON ALFONSO, NPI 1073508917, CMS profile ID 320483, IndustryPayments, General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–30 of 30 matching records. This page contains 30 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c. https://industrypayments.org/provider/npi-1073508917?year=2022&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2022 · Physicians and non-physician practitioners · CMS publication 2026-06-30

30 matching records · $435.13 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 30 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–30 of 30.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
GlaxoSmithKline, LLC. $28.7912/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944708965 CMS
GlaxoSmithKline, LLC. $21.5807/21/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944708973 CMS
Amgen Inc. $11.2706/06/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 940050187 CMS
Abbott Laboratories $15.7005/25/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 920477123 CMS
Novo Nordisk Inc $21.0005/03/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 902754167 CMS
GlaxoSmithKline, LLC. $22.2904/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944708957 CMS
GlaxoSmithKline, LLC. $0.8204/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944708967 CMS
Daiichi Sankyo Inc. $16.9403/30/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 930824735 CMS
Abbott Laboratories $12.8503/28/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 920477115 CMS
Amgen Inc. $11.2703/28/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 940050189 CMS
Otsuka America Pharmaceutical, Inc. $20.4203/21/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 929244905 CMS
GlaxoSmithKline, LLC. $0.9303/17/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944708971 CMS
GlaxoSmithKline, LLC. $21.9103/17/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944708981 CMS
PFIZER INC. $13.5403/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 949081879 CMS
Almatica Pharma LLC $13.9303/02/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 896638031 CMS
Novartis Pharmaceuticals Corporation $16.9403/01/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893493693 CMS
Kowa Pharmaceuticals America, Inc. $14.5902/24/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 900394381 CMS
Otsuka America Pharmaceutical, Inc. $16.1702/22/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 929244901 CMS
GlaxoSmithKline, LLC. $0.5202/17/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944708977 CMS
GlaxoSmithKline, LLC. $19.6102/17/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944708987 CMS
PFIZER INC. $16.3902/17/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 949122685 CMS
GlaxoSmithKline, LLC. $0.6502/16/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944708993 CMS
Merck Sharp & Dohme LLC $18.4502/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944538223 CMS
ABBVIE INC. $12.5102/09/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890483639 CMS
Astellas Pharma US Inc $22.3201/25/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 940108463 CMS
Amgen Inc. $14.8701/24/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 940050185 CMS
GlaxoSmithKline, LLC. $21.7701/20/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944708961 CMS
GlaxoSmithKline, LLC. $0.6901/20/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944708983 CMS
GlaxoSmithKline, LLC. $12.2401/13/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944708989 CMS
ABBVIE INC. $14.1701/10/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890483637 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $1,671.81 121
PY2020 $2,225.93 130
PY2021 $1,786.04 116
PY2022 $435.13 30
PY2023 $21.10 1
PY2024 $32.48 1

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024
Source files and profile matching
Source files
Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2021 Principal investigator $8,554.04 8
PY2020 Principal investigator $28,820.54 13
PY2019 Principal investigator $100,863.92 27

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2020

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

13 records in PY2020

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Adamas Pharmaceuticals, Inc. $6,585.02 11/18/2020 Non-covered Recipient Entity
NEW FRONTIER RESEARCH
A MULTICENTER OPEN-LABEL SAFETY AND EFFICACY STUDY OF ADS-5102 AMANTADINE EXTENDED RELEASE CAPSULES IN PATIENTS WITH MULTIPLE SCLEROSIS AND WALKING IMPAIRMENT No dispute reported 06/30/2026 750005919
Principal investigator 1 Adamas Pharmaceuticals, Inc. $120.00 11/18/2020 Non-covered Recipient Entity
NEW FRONTIER RESEARCH
A MULTICENTER OPEN-LABEL SAFETY AND EFFICACY STUDY OF ADS-5102 AMANTADINE EXTENDED RELEASE CAPSULES IN PATIENTS WITH MULTIPLE SCLEROSIS AND WALKING IMPAIRMENT No dispute reported 06/30/2026 750005921
Principal investigator 1 Adamas Pharmaceuticals, Inc. $120.00 11/18/2020 Non-covered Recipient Entity
NEW FRONTIER RESEARCH
A MULTICENTER OPEN-LABEL SAFETY AND EFFICACY STUDY OF ADS-5102 AMANTADINE EXTENDED RELEASE CAPSULES IN PATIENTS WITH MULTIPLE SCLEROSIS AND WALKING IMPAIRMENT No dispute reported 06/30/2026 750005925
Principal investigator 1 Adamas Pharmaceuticals, Inc. $149.50 10/28/2020 Non-covered Recipient Entity
NEW FRONTIER RESEARCH
A MULTICENTER OPEN-LABEL SAFETY AND EFFICACY STUDY OF ADS-5102 AMANTADINE EXTENDED RELEASE CAPSULES IN PATIENTS WITH MULTIPLE SCLEROSIS AND WALKING IMPAIRMENT No dispute reported 06/30/2026 750005831
Principal investigator 1 Adamas Pharmaceuticals, Inc. $19.50 10/23/2020 Non-covered Recipient Entity
NEW FRONTIER RESEARCH
A MULTICENTER OPEN-LABEL SAFETY AND EFFICACY STUDY OF ADS-5102 AMANTADINE EXTENDED RELEASE CAPSULES IN PATIENTS WITH MULTIPLE SCLEROSIS AND WALKING IMPAIRMENT No dispute reported 06/30/2026 750005821
Principal investigator 1 Adamas Pharmaceuticals, Inc. $933.14 08/26/2020 Non-covered Recipient Entity
NEW FRONTIER RESEARCH
A MULTICENTER OPEN-LABEL SAFETY AND EFFICACY STUDY OF ADS-5102 AMANTADINE EXTENDED RELEASE CAPSULES IN PATIENTS WITH MULTIPLE SCLEROSIS AND WALKING IMPAIRMENT No dispute reported 06/30/2026 750005669
Principal investigator 1 Adamas Pharmaceuticals, Inc. $7,686.43 06/03/2020 Non-covered Recipient Entity
NEW FRONTIER RESEARCH
A MULTICENTER OPEN-LABEL SAFETY AND EFFICACY STUDY OF ADS-5102 AMANTADINE EXTENDED RELEASE CAPSULES IN PATIENTS WITH MULTIPLE SCLEROSIS AND WALKING IMPAIRMENT No dispute reported 06/30/2026 750005353
Principal investigator 1 Adamas Pharmaceuticals, Inc. $1,862.07 05/15/2020 Non-covered Recipient Entity
NEW FRONTIER RESEARCH
A MULTICENTER OPEN-LABEL SAFETY AND EFFICACY STUDY OF ADS-5102 AMANTADINE EXTENDED RELEASE CAPSULES IN PATIENTS WITH MULTIPLE SCLEROSIS AND WALKING IMPAIRMENT No dispute reported 06/30/2026 750005281
Principal investigator 1 Adamas Pharmaceuticals, Inc. $4,414.66 04/22/2020 Non-covered Recipient Entity
NEW FRONTIER RESEARCH
A 3-ARM MULTICENTER DOUBLE-BLIND PLACEBO-CONTROLLED RANDOMIZED STUDY TO ASSESS THE EFFICACY AND SAFETY OF ADS-5102 AMANTADINE EXTENDED RELEASE CAPSULES IN MULTIPLE SCLEROSIS PATIENTS WITH WALKING IMPAIRMENT No dispute reported 06/30/2026 750004893
Principal investigator 1 Adamas Pharmaceuticals, Inc. $1,603.32 02/12/2020 Non-covered Recipient Entity
NEW FRONTIER RESEARCH
A 3-ARM MULTICENTER DOUBLE-BLIND PLACEBO-CONTROLLED RANDOMIZED STUDY TO ASSESS THE EFFICACY AND SAFETY OF ADS-5102 AMANTADINE EXTENDED RELEASE CAPSULES IN MULTIPLE SCLEROSIS PATIENTS WITH WALKING IMPAIRMENT No dispute reported 06/30/2026 750004283
Principal investigator 1 Adamas Pharmaceuticals, Inc. $1,610.15 01/22/2020 Non-covered Recipient Entity
NEW FRONTIER RESEARCH
A 3-ARM MULTICENTER DOUBLE-BLIND PLACEBO-CONTROLLED RANDOMIZED STUDY TO ASSESS THE EFFICACY AND SAFETY OF ADS-5102 AMANTADINE EXTENDED RELEASE CAPSULES IN MULTIPLE SCLEROSIS PATIENTS WITH WALKING IMPAIRMENT No dispute reported 06/30/2026 750003961
Principal investigator 1 Adamas Pharmaceuticals, Inc. $1,610.15 01/22/2020 Non-covered Recipient Entity
NEW FRONTIER RESEARCH
A 3-ARM MULTICENTER DOUBLE-BLIND PLACEBO-CONTROLLED RANDOMIZED STUDY TO ASSESS THE EFFICACY AND SAFETY OF ADS-5102 AMANTADINE EXTENDED RELEASE CAPSULES IN MULTIPLE SCLEROSIS PATIENTS WITH WALKING IMPAIRMENT No dispute reported 06/30/2026 750003965
Principal investigator 1 Adamas Pharmaceuticals, Inc. $2,106.60 01/03/2020 Non-covered Recipient Entity
NEW FRONTIER RESEARCH
A 3-ARM MULTICENTER DOUBLE-BLIND PLACEBO-CONTROLLED RANDOMIZED STUDY TO ASSESS THE EFFICACY AND SAFETY OF ADS-5102 AMANTADINE EXTENDED RELEASE CAPSULES IN MULTIPLE SCLEROSIS PATIENTS WITH WALKING IMPAIRMENT No dispute reported 06/30/2026 750003685